Breakthroughs in Non-Alcoholic Steatohepatitis Management

Monday, April 15, 2019 Drug News
Email Print This Page Comment bookmark
Font : A-A+

Multiple Investigational New Drugs with high potential for better treatment outcomes progressing through critical stages of clinical development

NEW YORK, April 15, 2019 /PRNewswire/ -- Read the full report: https://www.reportlinker.com/p05766144/?utm_source=PRN Non-Alcoholic

Steatohepatitis or NASH is a liver disorder that is characterized by the build-up of fat in liver in addition to inflammation and liver cell damage eventually progressing to cirrhosis. Currently lifestyle interventions are suggested for the treatment of NASH with no drugs having been approved for the condition.Multiple drugs are at the last stages of clinical trials with promising interim results while many more drugs are in early and mid-phase of clinical studies. Until now with no drugs approved for the condition of non-alcoholic steatohepatitis, there existed a huge unmet medical need.Poor performance of INDs tested for the condition of non-alcoholic steatohepatitis over the years has been attributed to poor preclinical models which has led to poor human translation of drug safety and efficacy in addition to use of conservative biomarkers during clinical trials.If companies can truly overcome the challenge of human translation of drug potential in terms of efficacy and safety, then non-alcoholic steatohepatitis as a manageable condition would be conquered within the next decade.The United States leads the way in the number of NASH-related patents published. The major challenge to demonstrate translation of clinical endpoint data in NASH trials has been to stop the disease progression to cirrhosis.Read the full report: https://www.reportlinker.com/p05766144/?utm_source=PRN About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001 

Cision View original content:http://www.prnewswire.com/news-releases/breakthroughs-in-non-alcoholic-steatohepatitis-management-300831866.html

SOURCE Reportlinker



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store